YSB Inc. (FRA:B1S)

Germany · Delayed Price · Currency is EUR

0.3200

-0.0100 (-3.03%)

At close: Jul 31, 2026

-71.43% (1Y)

Market Cap	240.51M -69.6%
Revenue (ttm)	2.55B +17.1%
Net Income	18.63M +409.7%
EPS	0.03 +378.3%
Shares Out	n/a
PE Ratio	12.91
Forward PE	n/a
Dividend	0.01 (3.96%)
Ex-Dividend Date	May 26, 2026

Volume	n/a
Open	0.3200
Previous Close	0.3300
Day's Range	0.3200 - 0.3200
52-Week Range	0.3020 - 1.2900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About YSB Inc.

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 2015

Employees 6,950

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol B1S

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY Financial Statements